Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermal Nevus Syndrome”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Very early researchUnknownNCT03993821
What this trial is testing

Burosumab for CSHS

Who this might be right for
Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)Epidermal Nevus Syndrome
Laura Tosi 1
Testing effectiveness (Phase 2)Looking for participantsNCT06789913
What this trial is testing

Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)Lymphatic MalformationsVascular Malformations+4 more
Relay Therapeutics, Inc. 277
Not applicableLooking for participantsNCT03001180
What this trial is testing

Identification of Biomarkers for Patients with Vascular Anomalies

Who this might be right for
Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform Hemangioendothelioma+4 more
Children's Hospital Medical Center, Cincinnati 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 980
Post-approval studies (Phase 4)Study completedNCT04320316
What this trial is testing

A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)

Who this might be right for
Epidermal Nevus Syndrome
University of Alabama at Birmingham 1
Not applicableLooking for participantsNCT06642051
What this trial is testing

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

Who this might be right for
Chronic Venous Insufficiency, CVIVenous MalformationsVenous Leg Ulcers+3 more
Sonablate 30
Large-scale testing (Phase 3)Study completedNCT03581591
What this trial is testing

Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets

Who this might be right for
HypophosphatemiaHypophosphatemic RicketsPain, Chronic
Redwood Dermatology Sciences 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285005
What this trial is testing

Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

Who this might be right for
Venous MalformationsLymphatic MalformationsKlippel-Trenaunay Syndrome+1 more
Kaken Pharmaceutical 150
Not applicableLooking for participantsNCT02399527
What this trial is testing

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Who this might be right for
Lymphatic MalformationGeneralized Lymphatic Anomaly (GLA)Central Conducting Lymphatic Anomaly+7 more
Boston Children's Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT02304367
What this trial is testing

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Who this might be right for
Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)
Kyowa Kirin, Inc. 17
Not applicableLooking for participantsNCT05563831
What this trial is testing

National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

Who this might be right for
PIK3CA-related Overgrowth SpectrumCLOVES SyndromeKlippel Trenaunay Syndrome+6 more
Institut National de la Santé Et de la Recherche Médicale, France 2,500
Testing effectiveness (Phase 2)Study completedNCT02722798
What this trial is testing

KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Who this might be right for
Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Kyowa Kirin Co., Ltd. 14
Testing effectiveness (Phase 2)WithdrawnNCT05195762
What this trial is testing

12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi

Who this might be right for
Epidermal NeviNevus Sebaceus
Albert Chiou